- Home
- FHB vs CPRX Comparison
FHB vs CPRX Comparison
Compare FHB & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHB
- CPRX
- Stock Information
- Founded
- FHB 1858
- CPRX 2002
- Country
- FHB United States
- CPRX United States
- Employees
- FHB N/A
- CPRX N/A
- Industry
- FHB Major Banks
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- FHB Finance
- CPRX Health Care
- Exchange
- FHB Nasdaq
- CPRX Nasdaq
- Market Cap
- FHB 3.0B
- CPRX 2.6B
- IPO Year
- FHB 2016
- CPRX 2006
- Fundamental
- Price
- FHB $24.38
- CPRX $21.34
- Analyst Decision
- FHB Sell
- CPRX Strong Buy
- Analyst Count
- FHB 9
- CPRX 5
- Target Price
- FHB $27.78
- CPRX $33.20
- AVG Volume (30 Days)
- FHB 1.2M
- CPRX 1.1M
- Earning Date
- FHB 10-24-2025
- CPRX 11-05-2025
- Dividend Yield
- FHB 4.27%
- CPRX N/A
- EPS Growth
- FHB 16.35
- CPRX 183.96
- EPS
- FHB 2.05
- CPRX 1.65
- Revenue
- FHB $824,314,000.00
- CPRX $558,499,000.00
- Revenue This Year
- FHB $10.40
- CPRX $16.59
- Revenue Next Year
- FHB $2.18
- CPRX $8.80
- P/E Ratio
- FHB $11.90
- CPRX $12.95
- Revenue Growth
- FHB 1.80
- CPRX 28.55
- 52 Week Low
- FHB $20.32
- CPRX $19.05
- 52 Week High
- FHB $28.80
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- FHB 49.99
- CPRX 56.55
- Support Level
- FHB $24.02
- CPRX $20.74
- Resistance Level
- FHB $24.70
- CPRX $21.74
- Average True Range (ATR)
- FHB 0.57
- CPRX 0.53
- MACD
- FHB 0.10
- CPRX 0.02
- Stochastic Oscillator
- FHB 69.22
- CPRX 71.62
About FHB First Hawaiian Inc.
First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).